📰 Prophase Lab News
Page 2 - Prophase Lab News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Prophase Lab. Real-time updates on events, politics, business and more.
October 19, 2022
Nebula Genomics Strengthens Advisory Board with Appointment of Russ Altman, M.D., Ph.D. - read this article along with other careers information, tips and advice on BioSpace
October 17, 2022
GARDEN CITY, NY, Oct. 17, 2022 -- ProPhase Labs, Inc. , a growth-oriented and diversified diagnostics, genomics and biotech company, today announced that its wholly owned subsidiary, Nebula... | October 17, 2022
September 6, 2022
GARDEN CITY, NY, Sept. 06, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and...
August 5, 2022
GARDEN CITY, NY, Aug. 04, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and...
July 21, 2022
ROCHESTER, N.Y., July 21, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and...
July 19, 2022
Garden City, NY, July 19, 2022 -- ProPhase Labs, Inc. , a diversified diagnostics and genomics company, today announced that it will host a live webcast on Thursday, July 21, 2022, at 11:30 a.m.... | July 19, 2022
June 29, 2022
ProPhase Labs Announces Formation of ProPhase BioPharma, Inc. (PBIO) for the Licensing and Development of Novel Drugs, Compounds and Biotechnology - read this article along with other careers information, tips and advice on BioSpace
June 28, 2022
28.06.2022 - Company Also Announces First Licensing Agreement for PBIO with Global BioLife, Inc. for broad based Anti-Viral Fighting Compounds Equivir and Equivir G Garden City, NY, June 28, 2022 (GLOBE NEWSWIRE) - ProPhase Labs, Inc. (NASDAQ: PRPH), a ... Seite 1
June 6, 2022
Analysts expect that ProPhase Labs, Inc. (NASDAQ:PRPH – Get Rating) will post $18.05 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for ProPhase Labs’ earnings, with the lowest sales estimate coming in at $13.39 million and the highest estimate coming in at $22.70 million. ProPhase Labs […]
June 4, 2022
Wall Street brokerages expect ProPhase Labs, Inc. (NASDAQ:PRPH – Get Rating) to report earnings per share of $0.17 for the current quarter, according to Zacks. Two analysts have issued estimates for ProPhase Labs’ earnings, with the highest EPS estimate coming in at $0.21 and the lowest estimate coming in at $0.12. ProPhase Labs reported earnings […]